Skip to main content

Table 1 Clinical and metabolic parameters in patients with IDM and NIDM at diagnosis

From: Non-immune-mediated versus immune-mediated type 1 diabetes: diagnosis and long-term differences—retrospective analysis

 

IDM group

(n = 29; 78.4%)

Mean ± SD

Median (IQR)

NIDM group

(n = 8; 21.6%)

Mean ± SD

Median (IQR)

p value

Clinical parameters

 Age (years)

23.0 (9)

38.1 ± 12.8

0.004*

 BMI (Kg/m2)

20.97 (3.5)

20.37 ± 2.7

0.435

 Family history type 1/2 DM (%)

17.2/37.9

12.5/37.5

0.999

 Symptoms duration (days)

21.8 ± 8.8

45.0 (60)

0.003*

 Presentation of the disease

  

0.744

 Arterial hypertension (%)

6.9

0

0.999

Metabolic parameters

 Plasma glucose at admission (mmol/L)

25.47 (8.16)

23.92 (8.66)

0.482

 HbA1c (%)

11.3 ± 2.2

11.8 (2.5)

0.794

 TDID (U)

46.4 ± 15.3

40.1 ± 12.3

0.301

 Dyslipidemia (%)

24.1

25.0

0.999

 Total-C (mmol/L)

8.77 (2.61)

9.05 (2.72)

0.585

 LDL-C (mmol/L)

5.57 ± 1.44

5.90 ± 1.47

0.579

 HDL-C (mmol/L)

2.75 ± 0.83

2.80 (0.50)

0.833

 Triglycerides (mmol/L)

4.73 (1.37)

3.72 (2.05)

0.555

  1. SD: standard deviation; IQR: interquartile range
  2. p* < 0.05: statistically significant difference
  3. Presentation of the disease: diabetic ketoacidosis; hyperglycemic hyperosmolar syndrome; polyuric polydipsic syndrome; diabetic ketoacidosis with hyperosmolarity; seizures